Corient Private Wealth LP decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 329,718 shares of the medical equipment provider's stock after selling 7,045 shares during the quarter. Corient Private Wealth LP owned approximately 0.09% of Intuitive Surgical worth $131,122,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of the company. California State Teachers Retirement System increased its holdings in shares of Intuitive Surgical by 39,531.1% in the second quarter. California State Teachers Retirement System now owns 213,725,958 shares of the medical equipment provider's stock valued at $84,994,539,000 after purchasing an additional 213,186,670 shares in the last quarter. State Street Corp boosted its position in Intuitive Surgical by 1.0% during the fourth quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider's stock worth $8,892,753,000 after purchasing an additional 162,264 shares during the period. Capital World Investors lifted its position in Intuitive Surgical by 1.7% during the fourth quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider's stock worth $4,449,491,000 after acquiring an additional 127,526 shares during the last quarter. Norges Bank bought a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $2,856,987,000. Finally, Invesco Ltd. boosted its position in shares of Intuitive Surgical by 17.4% in the fourth quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider's stock valued at $2,338,350,000 after acquiring an additional 611,268 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.
Insider Buying and Selling
In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the executive vice president owned 5,320 shares in the company, valued at $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89. Following the sale, the executive vice president directly owned 881 shares in the company, valued at $330,877.17. This represents a 8.04% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 11,281 shares of company stock worth $4,484,224. Corporate insiders own 0.60% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts recently commented on the company. HSBC cut Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price target on the stock. in a research report on Thursday, July 30th. Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday. JPMorgan Chase & Co. decreased their price target on shares of Intuitive Surgical from $550.00 to $450.00 and set an "overweight" rating for the company in a research note on Friday, July 17th. Sanford C. Bernstein reiterated an "outperform" rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Finally, Bank of America decreased their target price on shares of Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. Twenty-two research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $508.68.
Check Out Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Stock Performance
ISRG opened at $369.15 on Friday. The stock has a market capitalization of $130.41 billion, a price-to-earnings ratio of 42.29, a PEG ratio of 2.72 and a beta of 1.47. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The company has a fifty day moving average of $376.27 and a 200 day moving average of $423.82.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same period last year, the company earned $1.81 earnings per share. Intuitive Surgical's revenue was up 18.4% on a year-over-year basis. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.
The company's principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.
Recommended Stories
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.